• 20 Jan 26

Poolbeg Pharma on JPM 2026: Key Takeaways from Healthcare’s Premier Investment Event

Poolbeg Pharma on JPM 2026: Key Takeaways from Healthcare’s Premier Investment Event

Poolbeg Pharma PLC | POLB | 4.2 -0.05 (0.0%)

    • 3 views

 
Following attendance at the J.P. Morgan Healthcare Conference in San Francisco, Jeremy Skillington, CEO of Poolbeg Pharma, discusses the key themes shaping global healthcare in 2026 — from cancer immunotherapy and GLP-1 therapies to deal appetite and strategic partnerships — and what these insights mean for Poolbeg’s strategy in the year ahead.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Poolbeg Pharma: Delivering in 2025 and Positioning for a Breakout 2026

Companies: Poolbeg Pharma PLC

Poolbeg Pharma #POLB – CEO Jeremy Skillington talks to Alan Green

Companies: Poolbeg Pharma PLC

Poolbeg Pharma in MRC-backed cancer immunotherapy study

Companies: Poolbeg Pharma PLC

Poolbeg Pharma Presenting at the Proactive One2One Virtual Forum - 16th September 2021

Companies: Poolbeg Pharma PLC

Poolbeg Pharma, Solvonis Therapeutics, EMV Capital, Light Science Technologies, Coinsilium Group

Companies: Poolbeg Pharma PLC

Poolbeg Pharma - Interview with Elaine Sullivan

Companies: Poolbeg Pharma PLC

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top